Cell and gene therapies (CGTs) offer fresh hope to patients with serious and debilitating diseases, often where no other treatment options are available. Yet the process of getting to market and enabling patient access is far from simple. The complex clinical planning, potential for nuanced regulatory hurdles, payer scrutiny, and supply chain complexity all necessitate early and strategic planning to optimize patient access to these novel treatment options at launch.
In this webinar, experts will dive into:
- Payer engagement and why early payer communication planning is key
- Provider and treatment site support to simplify their experience
- Patient and caregiver engagement along the entire patient journey
Don’t miss this opportunity to hear experts weigh in on commercial planning to optimize patient access at launch. Register now to secure your spot.